Skip to content
★ Sign in to follow
UH

Ulf Hannelius

Executive
Chairman & CEO
Diamyd Medical AB
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€905
▼ Sales (0 ops.)
—

Latest filing published 05 May 2025 for Diamyd Medical AB, €905.

Filing timeline

BuySale
Ulf Hannelius

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Ulf Hannelius: trading record in brief

Only one filing by Ulf Hannelius is known so far (5 May 2025): an open-market purchase, €905, in Diamyd Medical AB. That is too little to draw conclusions. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Ulf Hannelius

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Verkställande direktör (VD)ExecutivesDiamyd Medical AB
    9,900 SEK0FI-SE
    1,000 shares@ SEK 9.90100.0% of flowBTU (betald tecknad unit)ISIN SE0024467914FI:A003N869-1
    Canonical exit: 3 Aug 2025 (T+90)

1 of 1 declaration